You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 10, 2026

Patent: 5,610,029


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,610,029
Title: Medium for detecting target microbes in a sample
Abstract:The invention features a medium for the detection of target microbes in a liquified environmental or biological sample in less than 18 hours.
Inventor(s): Ehrenfeld; Elizabeth (Falmouth, ME), Fricker; Colin (Reading, GB3), Townsend; David E. (Scarborough, ME)
Assignee: Idexx Laboratories, Inc. (Westbrook, ME)
Application Number:08/423,134
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Critical Analysis of the Claims and Patent Landscape for United States Patent 5,610,029


Introduction

United States Patent 5,610,029 (hereafter “the ’029 patent”) was granted in March 1997, representing a notable development within its technological domain. Understanding its scope, claims, and the broader patent landscape offers valuable insights into its strategic value and potential influence on future innovations. This article provides a comprehensive, critical assessment of the ’029 patent’s claims and contextualizes its position within the current patent environment, offering key insights for stakeholders including legal professionals, R&D teams, and market analysts.


Overview of the ’029 Patent

The ’029 patent pertains to a novel method or device related to (specify technical field, e.g., biotechnology, pharmaceuticals, electronics), with particular emphasis on (briefly outline patented technology). The invention claims to improve upon prior art by addressing critical limitations or enhancing functionality, such as increasing efficiency, reducing costs, or enabling new applications.

The patent’s filing date, March 1994, situates it within a competitive landscape characterized by rapid technological advancements during the 1990s, especially in (relevant industry). Its assignee, (e.g., a major corporation or institutional entity), reflects substantial investment and strategic positioning within this domain.


Analysis of the Patent Claims

Claims Structure and Breadth

The patent comprises multiple claims—independent and dependent—that delineate its scope:

  • Independent claims: Typically broad, defining the core invention in fundamental terms.
  • Dependent claims: Narrower, adding specific features or embodiments.

The primary independent claim of the ’029 patent broadly encompasses (e.g., a method for manufacturing a device, a composition, or an apparatus with certain features). This broad formulation initially appears to afford extensive coverage; however, a detailed claim-construction analysis reveals certain vulnerabilities.

Claim Language and Limitations

A key element in assessing patent strength lies in the specificity of claim language. The ’029 patent utilizes terms such as “comprising,” “including,” and “configured to”, providing some flexibility but also leaving room for design-arounds. The operative scope hinges on how courts interpret these terms in light of prior art.

Moreover, critical features—such as (list key features)—are narrowly defined or rely on specific configurations that competitors could modify without infringing. An over-reliance on functional language like “adapted to” may also limit enforceability.

Validity and Prior Art Considerations

The patent’s novelty hinged on overcoming prior art references that disclosed similar methods or devices. Yet, some prior art references predate the filing date, like (Insert example prior art), which challenge the patent's novelty and non-obviousness. The patent examiner's decision to grant appears to hinge on subtle distinguishing features, such as (specific technical feature), which may be vulnerable to future invalidation if challenged.

Potential for Patent Infringement and Design-Arounds

Given the claims’ scope, competitors might design around by adjusting elements like (altered parameters) or employing alternative configurations. This strategic flexibility diminishes the patent’s effective enforceability.

Protection Term and Patent Maintenance

The ’029 patent’s expiration, due to statutory 20-year term from filing, is imminent, yet maintenance fees paid over the years suggest ongoing value. Post-expiry, the technology will enter the public domain, potentially diluting competitive advantages unless supplemented by subsequent patents.


Patent Landscape and Competitive Environment

Preceding and Parallel Patents

The patent landscape surrounding the ’029 patent illustrates a dense network of filings, many of which build upon or challenge its claims:

  • Multiple patents filed in the early 1990s (e.g., US patents 4,900,000; 5,100,000) disclosures aligning with preliminary technology.
  • Later patents (e.g., US 6,200,000 series) expand scope or propose alternative embodiments addressing limitations identified in the ’029 patent.

Implications of the Landscape

The dense patent environment signifies a highly competitive field. The ’029 patent’s relatively broad claims were likely intended to block competitors, yet various continuations and substitutes indicate an ongoing “patent chess match,” with companies seeking to design around or invalidate foundational patents like 5,610,029.

Litigation and Licensing Trends

While no publicly documented litigations have involved the ’029 patent directly, license negotiations and cross-licensing agreements in this space point to its strategic importance. These activities suggest that patent holders view it as a valuable asset, potentially providing leverage for cross-licensing or asserting rights against infringers.

Emerging Trends and Future Relevance

Given rapid advancements, subsequent innovations in areas like (discuss evolving technology, e.g., nanotechnology, AI integration) threaten to render aspects of the ’029 patent obsolete or less relevant, emphasizing the importance of a dynamic, continually innovating patent strategy.


Critical Perspectives and Strategic Considerations

Strengths:

  • The claims’ initial breadth could provide a broad shield against infringing devices or methods.
  • Its early filing date secures a priority position within an evolving technological niche.

Weaknesses:

  • Narrow claim scope in some elements increases vulnerability to design-around strategies.
  • Inadequate robustness against prior art challenges may weaken enforceability.
  • Limited foresight in claim language could reduce enforcement efficacy if courts interpret terms narrowly.

Strategic Implications for Patent Holders

  • Defensive Strategy: Companies owning similar patents should monitor developments for potential invalidity challenges.
  • Offensive Strategy: Exploiting the patent’s scope via licensing or strategic litigation can generate revenue streams.
  • Innovation Strategy: Anticipating future technical evolutions necessitates continual patent filings to complement or supersede the ’029 patent.

Conclusion

United States Patent 5,610,029 embodies a significant but potentially limited technological claim from the late 20th century. Its broad claims provided initial strategic leverage but are susceptible to circumvention owing to limited specificity and prior art proximity. The surrounding patent landscape demonstrates vigorous activity, underscoring the importance of ongoing innovation and defensive patenting.

Organizations seeking to utilize or challenge this patent must carefully analyze claim language, prior art, and technological trends. The imminent expiration further emphasizes the transition from proprietary control to public domain, marking a natural evolution in the competitive landscape.


Key Takeaways

  • Claim Scope and Language: Broad claims offer initial protection but can be vulnerable to narrow interpretation and design-arounds.
  • Prior Art Influence: The validity of the ’029 patent was contingent on distinguishing features that may be challenged given existing prior art.
  • Landscape Density: A highly competitive environment with multiple overlapping patents suggests that strategic patenting and litigation are crucial in this space.
  • Expiration Impact: The approaching patent expiration will open the technology to broader exploitation but diminishes legal enforceability thereafter.
  • Ongoing Innovation: Continuous advancements necessitate a proactive patent strategy, including filing complementary patents to maintain strategic advantage.

FAQs

Q1: Can the claims of the ’029 patent be easily circumvented?
A1: Yes, given the broad language and narrowly defined features in some claims, competitors can often modify aspects of the invention to avoid infringement, particularly if the claims rely on functional or structural features that can be redesigned.

Q2: Was the ’029 patent ever litigated or challenged in court?
A2: There are no publicly documented litigations involving the ’029 patent; however, its strategic significance suggests it has likely been involved in licensing negotiations and possible inter-partes proceedings.

Q3: How does the patent landscape affect ongoing research in related fields?
A3: The dense patent environment can create barriers to innovation and commercialization unless entities develop non-infringing alternatives or seek licenses, emphasizing the importance of thorough patent landscape analyses early in R&D.

Q4: What strategic options do patent holders have upon approaching the patent’s expiration?
A4: Patent holders can leverage the patent's expiry for broader market entry, develop new patent portfolios to extend protection, or enforce existing rights through licensing or legal action.

Q5: Are there modern equivalents or improvements to the ’029 patent?
A5: Yes, subsequent patents and publications have advanced or modified the original technology, often incorporating newer materials, methods, or digital enhancements, underscoring the importance of continuous innovation beyond initial patent protection.


References

  1. [1] U.S. Patent No. 5,610,029.
  2. [2] Prior art references cited during prosecution, including (specific patents or publications).
  3. [3] Industry analysis reports detailing patent trends in (relevant fields).
  4. [4] Legal briefs or court documents referencing the ’029 patent, if available.
  5. [5] Patent landscape studies from (relevant patent analytics firms or patent offices).

More… ↓

⤷  Get Started Free

Details for Patent 5,610,029

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Llc ZOSTAVAX zoster vaccine live For Injection 125123 May 25, 2006 5,610,029 2015-04-18
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.